(MRVL) Marvell Technology - Overview
Sector: Technology | Industry: Semiconductors | Exchange: NASDAQ (USA) | Market Cap: 276.813m USD | Total Return: 282.1% in 12m
Avg Turnover: 5.82B
EPS Trend: 83.8%
Qual. Beats: 0
Rev. Trend: 88.5%
Qual. Beats: 0
Warnings
P/E ratio 108.7
Below Avwap Earnings
Tailwinds
Rs Leader, Idiosyncratic Leader, Confidence
Marvell Technology, Inc. designs and develops high-performance semiconductor solutions focused on data infrastructure. Its product portfolio includes system-on-a-chip (SoC) architectures, Ethernet switches, storage controllers, and optical interconnects. These components facilitate data movement and storage across data centers, carrier networks, and enterprise environments globally.
The company operates within the fabless semiconductor model, outsourcing the capital-intensive manufacturing of silicon wafers to third-party foundries while retaining control over design and intellectual property. This sector is currently driven by the increasing demand for specialized Application Specific Integrated Circuits (ASICs) and high-speed optical connectivity required for artificial intelligence workloads.
Further analysis of the companys valuation metrics on ValueRay can provide deeper insight into its market positioning. Marvell serves a diverse customer base through both direct sales and distribution networks, maintaining a significant presence in major technology hubs including the United States, China, and Southeast Asia.
- AI-driven demand for custom ASICs fuels high-margin data center revenue growth
- Optical interconnect product adoption accelerates due to hyperscale infrastructure expansion
- Cyclical recovery in carrier and enterprise networking markets stabilizes total turnover
- Geopolitical trade restrictions on high-performance semiconductors impact long-term China revenue
- Research and development spending on advanced process nodes pressures operating margins
| Net Income: 2.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.67 > 1.0 |
| NWC/Revenue: 59.51% < 20% (prev 13.78%; Δ 45.72% < -1%) |
| CFO/TA 0.08 > 3% & CFO 2.06b > Net Income 2.53b |
| Net Debt (1.75b) to EBITDA (4.59b): 0.38 < 3 |
| Current Ratio: 3.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (893.3m) vs 12m ago 2.02% < -2% |
| Gross Margin: 50.64% > 18% (prev 43.17%; Δ 7.47% > 0.5%) |
| Asset Turnover: 37.12% > 50% (prev 32.47%; Δ 4.65% > 0%) |
| Interest Coverage Ratio: 15.67 > 6 (EBIT TTM 3.31b / Interest Expense TTM 211.2m) |
| A: 0.19 (Total Current Assets 7.46b - Total Current Liabilities 2.28b) / Total Assets 26.9b |
| B: 0.05 (Retained Earnings 1.34b / Total Assets 26.9b) |
| C: 0.14 (EBIT TTM 3.31b / Avg Total Assets 23.5b) |
| D: 2.09 (Book Value of Equity 18.2b / Total Liabilities 8.73b) |
| Altman-Z'' = 4.56 = AA |
| DSRI: 1.22 (Receivables 1.87b/1.14b, Revenue 8.72b/6.50b) |
| GMI: 0.85 (GM 43.17% / 50.64%) |
| AQI: 0.89 (AQ_t 0.68 / AQ_t-1 0.76) |
| SGI: 1.34 (Revenue 8.72b / 6.50b) |
| TATA: 0.02 (NI 2.53b - CFO 2.06b) / TA 26.9b) |
| Beneish M = -2.80 (Cap -4..+1) = A |
As of June 08, 2026, the stock is trading at USD 263.47 with a total of 88,753,188 shares traded.
Over the past week, the price has changed by +28.52%,
over one month by +64.66%,
over three months by +184.51% and
over the past year by +282.10%.
Marvell Technology has received a consensus analysts rating of 4.49. Therefore, it is recommended to buy MRVL.
- StrongBuy: 23
- Buy: 9
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 233.1 | -11.5% |
P/E Trailing = 108.7388
P/E Forward = 71.9424
P/S = 30.2719
P/B = 13.965
P/EG = 1.6434
Revenue TTM = 8.72b USD
EBIT TTM = 3.31b USD
EBITDA TTM = 4.59b USD
Long Term Debt = 4.96b USD (from longTermDebt, last quarter)
Short Term Debt = 54.5m USD (from shortTermDebt, last quarter)
Debt = 5.59b USD (from shortLongTermDebtTotal, last quarter) + Leases 315.9m
Net Debt = 1.75b USD (calculated: Debt 5.59b - CCE 3.84b)
Enterprise Value = 279b USD (277b + Debt 5.59b - CCE 3.84b)
Interest Coverage Ratio = 15.67 (Ebit TTM 3.31b / Interest Expense TTM 211.2m)
EV/FCF = 167.4x (Enterprise Value 279b / FCF TTM 1.66b)
FCF Yield = 0.60% (FCF TTM 1.66b / Enterprise Value 279b)
FCF Margin = 19.09% (FCF TTM 1.66b / Revenue TTM 8.72b)
Net Margin = 28.99% (Net Income TTM 2.53b / Revenue TTM 8.72b)
Gross Margin = 50.64% ((Revenue TTM 8.72b - Cost of Revenue TTM 4.30b) / Revenue TTM)
Gross Margin QoQ = 52.15% (prev 48.37%)
Tobins Q-Ratio = 10.34 (Enterprise Value 279b / Total Assets 26.9b)
Interest Expense / Debt = 3.78% (Interest Expense 211.2m / Debt 5.59b)
Taxrate = 13.29% (387.3m / 2.91b)
NOPAT = 2.87b (EBIT 3.31b * (1 - 13.29%))
Current Ratio = 3.28 (Total Current Assets 7.46b / Total Current Liabilities 2.28b)
Debt / Equity = 0.31 (Debt 5.59b / totalStockholderEquity, last quarter 18.2b)
Debt / EBITDA = 0.38 (Net Debt 1.75b / EBITDA 4.59b)
Debt / FCF = 1.05 (Net Debt 1.75b / FCF TTM 1.66b)
Total Stockholder Equity = 15.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.76% (Net Income 2.53b / Total Assets 26.9b)
RoE = 16.84% (Net Income TTM 2.53b / Total Stockholder Equity 15.0b)
RoCE = 16.58% (EBIT 3.31b / Capital Employed (Equity 15.0b + L.T.Debt 4.96b))
RoIC = 11.82% (NOPAT 2.87b / Invested Capital 24.3b)
WACC = 16.66% (E(277b)/V(282b) * Re(16.93%) + D(5.59b)/V(282b) * Rd(3.78%) * (1-Tc(0.13)))
Discount Rate = 16.93% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 40.45 | Cagr: 1.46%
[DCF] Terminal Value 55.71% ; FCFF base≈1.55b ; Y1≈1.77b ; Y5≈2.61b
[DCF] Fair Price = 15.94 (EV 15.7b - Net Debt 1.75b = Equity 13.9b / Shares 874.8m; r=16.66% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 83.76 | EPS CAGR: 53.53% | SUE: 0.03 | # QB: 0
Revenue Correlation: 88.48 | Revenue CAGR: 20.04% | SUE: 0.48 | # QB: 0
EPS current Quarter (2026-07-31): EPS=0.93 | Chg30d=+3.00% | Revisions=+69% | Analysts=33
EPS next Quarter (2026-10-31): EPS=1.07 | Chg30d=+6.35% | Revisions=+88% | Analysts=31
EPS current Year (2027-01-31): EPS=4.05 | Chg30d=+5.72% | Revisions=+89% | GrowthEPS=+42.5% | GrowthRev=+40.6%
EPS next Year (2028-01-31): EPS=6.17 | Chg30d=+13.79% | Revisions=+84% | GrowthEPS=+52.5% | GrowthRev=+44.7%
[Analyst] Revisions Ratio: +89%